PAHC logo
PAHC NASDAQ US

Phibro Animal Health Corporation - Class A Common Stock

Healthcare · Pharmaceuticals Website · IPO Apr 2014
$55.52
▲ +$0.76 (+1.39%)
Vol 246K
12
Quality Score
ok
Deep Check
2/5 ok
Mkt Cap
$1.5B
P/E
22.4
ROE
24.4%
Margin
4.9%
D/E
238.37
Beta
0.79
Div Yield
1.28%
52W
$16–$46

Wall Street Consensus

9 analysts · Apr 2026
0
Strong Buy
1
Buy
4
Hold
2
Sell
2
Strong Sell
11.1%
Buy Rating

Price Chart

Similar Stocks

AMRX
Amneal Pharmaceuticals Inc
P/E 671.4
$4.0B
ELVN
Enliven Therapeutics Inc
$913.9M
NKTR
Nektar Therapeutics
$860.0M
DFTX
Definium Therapeutics Inc
OCUL
Ocular Therapeutix Inc
$2.6B

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.68 $0.87 +$0.19
Sep 2025 $0.64 $0.73 +$0.10
Jun 2025 $0.53 $0.57 +$0.04
Mar 2025 $0.53 $0.63 +$0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 18.3% 12.4% 18.3% 18.3% 24.4% 24.4%
P/E (TTM) 21.45 40.61 34.27 35.32 24.34 22.36
Net Margin 4.5% 2.7% 3.7% 3.7% 4.8% 4.8%
Gross Margin 29.7% 32.3% 31.6% 31.6% 31.9% 31.9%
D/E Ratio 251.57 273.47 251.57 251.57 238.37 238.37
Current Ratio 2.76 2.91 2.76 2.76 3.09 3.09

Key Ratios

ROA (TTM)
5.1%
P/S (TTM)
1.08
P/B
3.6
EPS (TTM)
$1.66
CF/Share
$1.36
Rev Growth 3Y
+11.2%
52W High
$46.42
52W Low
$16.16
$16.16 52-Week Range $46.42

How does PAHC compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

PAHC AARD ACB ACRS ADIL

PAHC valuation vs Pharmaceuticals peers

P/E ratio
22.4
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1.1
▼ 78% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
3.6
▲ 71% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
1.3%
▼ 37% below peers (2.0%)
vs Peers
vs Industry
Low yield

PAHC profitability vs Pharmaceuticals peers

ROE
24.4%
▲ 145% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
4.9%
▲ 110% above peers (-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
31.9%
▼ 53% below peers (68.3%)
vs Peers
vs Industry
Weak
ROA
5.1%
▲ 114% above peers (-37.4%)
vs Peers
vs Industry
Top tier

PAHC financial health vs Pharmaceuticals peers

D/E ratio
238.4
▲ 15379% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
3.1
▼ 8% below peers (3.4)
vs Peers
vs Industry
In line
Beta
0.8
▼ 16% below peers (0.9)
vs Peers
vs Industry
More volatile

PAHC fundamentals radar

PAHC Peer median Industry

PAHC profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

PAHC vs peers: key metrics

Latest News

No related news yet